Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

C

COAG

Hemab Therapeutics Holdings Inc

46.88

Aug 04 • 1:45 PM ET +1.88 (4.19%)

Healthcare Biotechnology USA Mid NASD

Peers: LABT VBIO ABVE ABVC ACET AARD AAPG ABEO ABOS ABCL

| Held by: VTI VXF SCHA TMSL SCHB VTWO MSSM VTWG TNXT VTWV

Scroll to Statements

Index	-
Market Cap	2.19B
Enterprise Value	2.39B
Income	-
Sales	-
Book/sh	-4.25
Cash/sh	3.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	72
IPO	May 01, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	13.39
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	12.85
Current Ratio	12.85
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.51
EPS next Q	-0.73
EPS this Y	95.85%
EPS next Y	10.40%
EPS next 5Y	63.92%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Jun 03
EPS/Sales Surpr.	-1.05% -

Insider Own	28.79%
Insider Trans	28.36%
Inst Own	33.10%
Inst Trans	8.52%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	4.37%
SMA50	33.71%
SMA200	41.44%
Trades

Shs Outstand	46.71M
Shs Float	33.26M
Short Float	4.99%
Short Ratio	5.16
Short Interest	1.66M
52W High	52.15 -10.09%
52W Low	23.00 103.85%
Volatility	11.03% 10.79%
ATR (14)	4.25
RSI (14)	58.82
Beta	-
Rel Volume	1.36
Avg Volume	321.61K
Volume	294,124

Perf Week	-0.79%
Perf Month	56.44%
Perf Quarter	85.02%
Perf Half Y	-
Perf YTD	73.65%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	50.00
Prev Close	45.00
Price	46.88
Change	4.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)